Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
Номер патента: EP1225900A1
Опубликовано: 31-07-2002
Автор(ы): Wolfgang Eisert
Принадлежит: Boehringer Ingelheim Pharma GmbH and Co KG
Опубликовано: 31-07-2002
Автор(ы): Wolfgang Eisert
Принадлежит: Boehringer Ingelheim Pharma GmbH and Co KG
Реферат: A method of treatment of the human or non-human animal body for treating fibrin-dependent microcirculation disorders is disclosed, for example microcirculation disorders caused by metabolic diseases, inflammatory reactions or autoimmune diseases, furthermore peripheral microcirculation disorders or microcirculation disorders associated with increased cell fragmentation, which method comprises administering to a human or non-human animal body in need of such treatment an effective amount of a pharmaceutical composition containing a pyrimido-pyrimidine selected from dipyridamole, mopidamol and the pharmaceutically acceptable salts thereof, and the use of said pyrimido-pyrimidine for the manufacture of a corresponding pharmaceutical composition.
Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
Номер патента: NZ518525A. Автор: Wolfgang Eisert. Владелец: BOEHRINGER INGELHEIM PHARMA. Дата публикации: 2004-04-30.